Clinical Trial Update: Extension Study in Primary Distal Renal Tubular Acidosis [Phase 3]

View source ↗

Summary

Advicenne Pharma has withdrawn its Phase 3 extension study for primary distal renal tubular acidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Renal Tubular Acidosis

Drugs mentioned

• ADV7103

Snippet

Sponsor: Advicenne Pharma | Conditions: Acidosis, Renal Tubular | Phase 3 | Status: WITHDRAWN